New York State Common Retirement Fund
QNCX icon

New York State Common Retirement Fund’s Quince Therapeutics QNCX Stock Holding History

New York State Common Retirement Fund’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1
Closed – – 3416
2022
Q2 		$0 Sell
1
-71
-99% -$50.2K ﹤0.01% 3525
2022
Q1 		$89K Hold
72
– – ﹤0.01% 3051
2021
Q4 		$181K Hold
72
– – ﹤0.01% 2908
2021
Q3 		$1.32M Sell
72
-14
-16% -$223K ﹤0.01% 1990
2021
Q2 		$913K Buy
86
+14
+19% +$117K ﹤0.01% 2279
2021
Q1 		$519K Hold
72
– – ﹤0.01% 2436
2020
Q4 		$400K Hold
72
– – ﹤0.01% 2456
2020
Q3 		$720K Hold
72
– – ﹤0.01% 2051
2020
Q2 		$667K Buy
72
+20
+38% +$183K ﹤0.01% 2071
2020
Q1 		$470K Hold
52
– – ﹤0.01% 2073
2019
Q4 		$578K Buy
52
+37
+247% +$223K ﹤0.01% 2228
2019
Q3 		$75K Hold
15
– – ﹤0.01% 3100
2019
Q2 		$128K Buy
+15
New +$89.6K ﹤0.01% 3020

Other funds holding QNCX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHAM
Pacific Heights Asset Management San Francisco, California $2.99B AUM 52.5% 1-Year Est. Return

New York State Common Retirement Fund's QNCX Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Quince Therapeutics (QNCX) in Q3 2022, closing a stake of 1 share.

New York State Common Retirement Fund first reported a position in QNCX in Q2 2019 and held it in 13 quarters. The position peaked at $1.32M in Q3 2021. 58 funds tracked by Wall St. Rank hold QNCX as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Quince Therapeutics position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 1 Quince Therapeutics share in Q3 2022.
  • New York State Common Retirement Fund first reported a position in Quince Therapeutics in Q2 2019 and held it in 13 quarters.
  • New York State Common Retirement Fund's Quince Therapeutics position peaked at $1.32M in Q3 2021.
  • 58 funds tracked by Wall St. Rank held Quince Therapeutics as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.